Novelix Pharmaceuticals Appoints New Directors and Secretarial Auditor
Trimurthi Limited, a Hyderabad-based pharmaceutical company, held its 31st Annual General Meeting on September 19, 2025. The company appointed two new directors: Mr. Gattu Gnana Prakash as Non-Executive Non-Independent Director and Ms. Mayuri Baidya as Non-Executive Independent Director. M/s Khushbu Kanwar & Co. was appointed as the Secretarial Auditor for a five-year term. All resolutions, including new appointments and corporate actions, were passed with overwhelming majority. Other approved actions include adopting financial statements, re-appointing a director, increasing borrowing limits, and authorizing various financial transactions.

*this image is generated using AI for illustrative purposes only.
Trimurthi Limited, a pharmaceutical company based in Hyderabad, has announced significant changes to its board and auditing structure following its 31st Annual General Meeting (AGM) held on September 19, 2025.
New Board Appointments
The shareholders of Trimurthi have approved the appointment of two new directors to the company's board:
Mr. Gattu Gnana Prakash has been appointed as a Non-Executive Non-Independent Director. Mr. Prakash, an IIT-Chennai graduate, brings over 25 years of experience in management and information technology to the board.
Ms. Mayuri Baidya joins as a Non-Executive Independent Director for a five-year term, effective August 14, 2025. Ms. Baidya, who holds a Post Graduate degree in Commerce from the University of Rajasthan, has extensive experience in accounting and finance.
New Secretarial Auditor
In addition to the board appointments, the shareholders approved the appointment of M/s Khushbu Kanwar & Co. as the company's Secretarial Auditor for a five-year term, from April 1, 2025, to March 31, 2030.
Voting Results
The company reported that all resolutions presented at the AGM were passed with overwhelming majority. Key voting results include:
Resolution | Votes in Favor (%) | Votes Against (%) |
---|---|---|
Appointment of Ms. Mayuri Baidya | 99.99 | 0.00 |
Appointment of Mr. Gattu Gnana Prakash | 99.99 | 0.00 |
Appointment of Secretarial Auditor | 99.99 | 0.00 |
Other Corporate Actions
The AGM also saw the approval of several other important resolutions:
- Adoption of financial statements for the year ended March 31, 2025.
- Re-appointment of Mr. Jivamohan Divakar Valluri as a Non-Executive Director.
- Approval for increasing the borrowing limit under section 180(1)(c) of the Companies Act 2013.
- Approval for creation of mortgage or charge on the company's assets under Section 180(1)(a) of the Companies Act, 2013.
- Authorization to make investments, give loans, guarantees, and provide securities under Section 186 of the Companies Act, 2013.
- Approval of transactions under Section 185 of the Companies Act, 2013.
These appointments and corporate actions reflect Trimurthi's commitment to strengthening its governance structure and strategic positioning in the pharmaceutical sector. The diverse experience of the new board members is expected to contribute to the company's future growth and development.
Historical Stock Returns for Trimurthi
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-4.41% | +7.73% | +10.79% | +70.24% | +70.24% | +70.24% |